Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronald Blum

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Journal of Oncology Practice|February 16, 2018
What's New With ASCO.org ?Ronald Blum
The Permanente Journal|April 5, 2011
"You gotta be crazy!" tales of my practice in rural maineRonald Blum
The Breast Journal|June 11, 2008
Paraneoplastic cerebellar degeneration with anti-Yo antibody in a patient with HER2/neu overexpressing breast cancer: a case report with a current literature reviewShin Ogita, Omar H Llaguna, Sheldon M Feldman, et al.
American Journal of Hematology|June 17, 2010
Association of age, gender, and weight on maintenance dose of intravenous unfractionated heparinSiddharth Verma, Shumei Kato, Ronald Blum, et al.
JCO Oncology Practice|June 20, 2020
Evaluation of a Virtual Learning Collaborative to Integrate Palliative Care Into Routine Oncology PracticeArif H Kamal, Heidi Bossley, Ronald Blum, et al.
Cancer|September 5, 2002
Immunomodulatory effects of high-dose and low-dose interferon alpha2b in patients with high-risk resected melanoma: the E2690 laboratory corollary of intergroup adjuvant trial E1690John M Kirkwood, Thomas Richards, Hassane M Zarour, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Journal of Oncology Practice|February 16, 2018
What's New With ASCO.org ?Ronald Blum
The Permanente Journal|April 5, 2011
"You gotta be crazy!" tales of my practice in rural maineRonald Blum
The Breast Journal|June 11, 2008
Paraneoplastic cerebellar degeneration with anti-Yo antibody in a patient with HER2/neu overexpressing breast cancer: a case report with a current literature reviewShin Ogita, Omar H Llaguna, Sheldon M Feldman, et al.
American Journal of Hematology|June 17, 2010
Association of age, gender, and weight on maintenance dose of intravenous unfractionated heparinSiddharth Verma, Shumei Kato, Ronald Blum, et al.
JCO Oncology Practice|June 20, 2020
Evaluation of a Virtual Learning Collaborative to Integrate Palliative Care Into Routine Oncology PracticeArif H Kamal, Heidi Bossley, Ronald Blum, et al.
Cancer|September 5, 2002
Immunomodulatory effects of high-dose and low-dose interferon alpha2b in patients with high-risk resected melanoma: the E2690 laboratory corollary of intergroup adjuvant trial E1690John M Kirkwood, Thomas Richards, Hassane M Zarour, et al.
Pageof 1